COLLECTIONS
WORKFLOWS
Celgene Corporation is a pharmaceutical company that specializes in developing and commercializing innovative therapies for cancer and immune-inflammatory-related diseases. It was acquired by Bristol Myers Squibb, a global biopharmaceutical company, in 2019.
Focus Areas
Notable Investments
